Free Trial

Alpha Teknova Q2 2023 Earnings Report

Alpha Teknova logo
$8.66 +0.05 (+0.58%)
(As of 10:28 AM ET)

Alpha Teknova EPS Results

Actual EPS
-$0.25
Consensus EPS
-$0.26
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Alpha Teknova Revenue Results

Actual Revenue
$11.53 million
Expected Revenue
$9.60 million
Beat/Miss
Beat by +$1.93 million
YoY Revenue Growth
N/A

Alpha Teknova Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

"X-Ray Vision" could find thousands of hidden market opportunities (Ad)

Let me show you how I trade with “X-Ray vision.” You see, most “trend” traders only use one trend filter when looking for an optimal buy signal. And that can be a big mistake because you can’t see if you’re in a “True Trend.” But my newest trading tool is designed to only target the best, most stable stocks… Using 3 trend filters… which are these green, yellow, and red lines.

Just tap here to join the presentation.

Alpha Teknova Earnings Headlines

TD Cowen Reaffirms Their Buy Rating on Alpha Teknova (TKNO)
Will the Nasdaq 100 crash?
In a world where some top money managers say you should “diversify” with a basket of stocks to help lower risk in your portfolio… And others say you should focus on only one ticker at a time because you can’t really keep detailed tabs on 10, 20 or more stocks at once… My #1 strategy to play the Nasdaq bull run has shown the power to provide the best of BOTH worlds at the same time. Because it harnesses ONE ticker that bottles up all the firepower of Apple, Nvidia, Tesla and more into one place… While I cannot promise future returns or against losses… This strategy targets major payouts OVERNIGHT!
Alpha Teknova Reports Strong Q3 Revenue Growth
See More Alpha Teknova Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Teknova? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Teknova and other key companies, straight to your email.

About Alpha Teknova

Alpha Teknova (NASDAQ:TKNO) produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

View Alpha Teknova Profile

More Earnings Resources from MarketBeat

Upcoming Earnings